|
NF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.879830E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.444900E-03 |
| Normal-vs-Stage2 |
6.471900E-02 |
| Normal-vs-Stage3 |
5.998300E-04 |
| Normal-vs-Stage4 |
6.642100E-03 |
| Stage1-vs-Stage2 |
7.695200E-01 |
| Stage1-vs-Stage3 |
2.370000E-01 |
| Stage1-vs-Stage4 |
5.756800E-01 |
| Stage2-vs-Stage3 |
2.564600E-01 |
| Stage2-vs-Stage4 |
4.670800E-01 |
| Stage3-vs-Stage4 |
7.359000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.806900E-04 |
| Normal-vs-AfricanAmerican |
6.657200E-01 |
| Normal-vs-Asian |
2.572200E-02 |
| Caucasian-vs-AfricanAmerican |
4.779800E-02 |
| Caucasian-vs-Asian |
5.918600E-01 |
| AfricanAmerican-vs-Asian |
1.595430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.572700E-04 |
| Normal-vs-Female |
5.137300E-03 |
| Male-vs-Female |
3.867000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.329500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.621400E-03 |
| Normal-vs-Age(61-80Yrs) |
8.195100E-04 |
| Normal-vs-Age(81-100Yrs) |
4.526200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.778000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.230600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.539800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.515400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.532600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.220200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.833700E-02 |
| Classical-VS-Follicular |
2.453800E-01 |
| Classical-VS-Other |
2.374000E-01 |
| Classical-VS-Normal |
1.802410E-02 |
| Tall-VS-Follicular |
3.570200E-01 |
| Tall-VS-Other |
7.514600E-01 |
| Tall-VS-Normal |
9.967300E-04 |
| Follicular-VS-Other |
5.374400E-01 |
| Follicular-VS-Normal |
1.034110E-02 |
| Other-VS-Normal |
5.612100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.787700E-04 |
| Normal-vs-N1 |
1.069760E-02 |
| N0-vs-N1 |
9.519000E-01 |
|
|
